Patients over Patents: The Left alternative for a Public EU Pharma Industry
2026-06-09T07:00:00+00:00
2026-06-09T10:30:00+00:00
https://www.expert-europe.eu//medias/image/thumbnail_9112952776a08c8ce1c6c5.png
European Parliament
Rue Wiertz 60
Brussels
1047
BE
The Left Group | Hosted by MEPs Anthony SMITH (LFI, FR), Marc BOTENGA (PTB-PVDA, BE) & Catarina MARTINS (BE, PT). Join policymakers and health experts on 09/06/2026 at the European Parliament in Brussels for a strategic discussion on EU pharmaceutical sovereignty and the public interest. The Left EVENT Patients over Patents: The Left alternative for a Public EU Pharma Industry 📅 Date:09/06/2026 🕐 Time:09:00 - 12:30 📍 Location:Room SPINELLI 1G2, European Parliament (Brussels) About the Event This event brings together policymakers, trade unionists, public health experts and practitioners for a strategic discussion on developing a left-wing alternative for European pharmaceutical sovereignty. Panels will examine the shortcomings of current EU industrial policy, the consequences of medicine shortages for patients and healthcare systems, and the influence of the pharmaceutical industry.The discussion will address the structural dynamics shaping medicine production today, including supply chain vulnerabilities and corporate interests driving EU legislation. In response, the event will present concrete policy alternatives: translating political analysis into actionable proposals for a pharmaceutical industry that serves the public interest.Hosted by +Anthony SMITHMEP France Member of the European Parliament Left The Left group in the European Parliament – GUE/NGL | LFI La France Insoumise Anthony SMITHCommitteesITREIndustry, Research & EnergyAFCOConstitutional AffairsCULTCulture & EducationDelegationsDANDDAND DelegationDLATDelegation to the Euro-Latin American Parliamentary Assembly×+Marc BOTENGAMEP Belgium The Left Vice-ChairMember of the European Parliament Left The Left group in the European Parliament – GUE/NGL | PTB-PVDA PVDA-PTB Marc BOTENGACommitteesAFETForeign AffairsSEDESecurity & Defence (Subcommittee)ECONEconomic & Monetary AffairsITREIndustry, Research & EnergyFISCTax Matters (Subcommittee)DelegationsDACPDelegation to the ACP-EU Joint Parliamentary AssemblyDAFRDAFR DelegationDPALDPAL Delegation×+Catarina MARTINSMEP Portugal The Left BureauMember of the European Parliament Left The Left group in the European Parliament – GUE/NGL | BE Bloco de Esquerda Catarina MARTINSCommitteesENVIEnvironment, Public Health & Food SafetySANTPublic Health (Subcommittee)ECONEconomic & Monetary AffairsEMPLEmployment & Social AffairsITREIndustry, Research & EnergyDelegationsV-CHAIR DACPDelegation to the ACP-EU Joint Parliamentary AssemblyV-CHAIR DCABDCAB DelegationD-BRDelegation for relations with the Federative Republic of Brazil×Speakers ⬇ ProgrammeHadrien CLOUETDeputy of the French National AssemblyLFI Judith KIRTON-DARLINGGeneral SecretaryIndustriALL Massimo FLORIOHealth economist Antoine PRIOUXFrench pharmacistP4pillon Gaëlle KRIKORIANAuthor on pharmaceutical policy Sandrine CARISTANUnion representativeSanofiJose Aranda da SILVAPortuguese pharmacistspecialist in medicine policyProgramme Opening Remarks Anthony Smith | Member of the European Parliament | The Left. Hadrien Clouet | Deputy of the French National Assembly | LFI. Medicines production in Europe today: assessing industrial sovereignty and affordable access Moderation: Marc Botenga | Member of the European Parliament,The Left. Judith Kirton-Darling | General Secretary | IndustriALL. Massimo Florio | Health economist (TBC). Left-wing alternatives for pharmaceutical industrial policy: ensuring sustainability and affordable access to medicines Moderation: Catarina Martins | Member of the European Parliament,The Left. Antoine Prioux | French pharmacist. Gaëlle Krikorian | Author on pharmaceutical policy | Author of a position paper on the public pharmaceutical sector. Sandrine Caristan | Union representative at Sanofi. Jose Aranda da Silva | Portuguese pharmacist | Specialist in medicine policy (TBC). Closing Remarks Anthony Smith | Member of the European Parliament | The Left. Important – This event is by invitation, and only registered participants will be admitted. Due to capacity constraints, all attendees must register, including those already holding a European Parliament access badge. Registration is mandatory for admission.
.flip-card {
perspective: 1000px;
position: relative;
min-height: 380px;
z-index: 1;
}
.flip-card:hover,
.flip-card:focus-within {
z-index: 50;
}
.flip-checkbox {
display: none;
}
.flip-card-inner {
position: relative;
width: 100%;
height: 100%;
transition: transform 0.6s;
transform-style: preserve-3d;
}
.flip-checkbox:checked ~ .flip-card-inner {
transform: rotateY(180deg);
}
.flip-checkbox:checked ~ .flip-card-inner .flip-card-front {
pointer-events: none;
}
.flip-checkbox:not(:checked) ~ .flip-card-inner .flip-card-back {
pointer-events: none;
}
.flip-card,
.flip-card-inner,
.flip-card-back {
overflow: visible !important;
}
.flip-card-front,
.flip-card-back {
position: absolute;
width: 100%;
backface-visibility: hidden;
border-radius: 12px;
min-height: 380px;
box-sizing: border-box !important;
}
.flip-card-front {
display: flex;
flex-direction: column;
align-items: center;
justify-content: flex-start;
padding: 20px 15px;
text-align: center;
position: relative;
}
.flip-card-back {
transform: rotateY(180deg);
padding: 20px;
overflow: visible !important;
border: 1px solid #e8edf4;
}
.flip-card-front::before {
content: '';
position: absolute;
bottom: 0;
left: 0;
width: 50px;
height: 50px;
background: linear-gradient(135deg, #fce9e9 0%, #fef4f4 100%);
clip-path: polygon(0 100%, 100% 100%, 0 0);
opacity: 1;
z-index: 0;
}
.flip-card-front label[for^="flip-"],
.flip-card-front label[for^="speaker-"] {
position: absolute;
bottom: 6px;
left: 10px;
font-size: 18px;
font-weight: 300;
cursor: pointer;
z-index: 10;
background: none;
border: none;
padding: 0;
transition: transform 0.2s, color 0.2s;
color: #e42728;
}
.flip-card-front label[for^="flip-"]:hover,
.flip-card-front label[for^="speaker-"]:hover {
color: #b81e1e;
transform: scale(1.2);
}
.close-button {
position: absolute;
top: 15px;
right: 15px;
width: 28px;
height: 28px;
background: #e42728;
color: #fff;
border-radius: 50%;
display: flex;
align-items: center;
justify-content: center;
font-size: 24px;
font-weight: 300;
cursor: pointer;
z-index: 100;
line-height: 1;
transition: all 0.2s;
}
.close-button:hover {
background: #b81e1e;
transform: rotate(90deg) scale(1.1);
}
.social-icon {
transition: transform 0.2s ease, box-shadow 0.2s ease;
}
.social-icon:hover {
transform: translateY(-3px);
box-shadow: 0 6px 12px rgba(0, 0, 0, 0.15);
}
.logo-link img {
transition: transform 0.2s ease, filter 0.2s ease;
}
.logo-link:hover img {
transform: scale(1.1);
filter: brightness(1.1);
}
.static-card .flip-card-front::before {
display: none !important;
}
.static-card {
transition: transform 0.2s ease, box-shadow 0.2s ease;
border: none !important;
box-sizing: border-box !important;
}
.static-card:hover {
transform: translateY(-4px);
box-shadow: 0 12px 30px rgba(228, 39, 40, 0.15) !important;
}
.bio-content-mep strong {
color: #e42728;
font-size: 16px;
display: block;
margin-bottom: 15px;
text-align: center;
font-weight: 700;
padding-bottom: 12px;
border-bottom: 2px solid #e42728;
}
.bio-section-title {
font-size: 11px;
color: #64748b;
font-weight: 700;
text-transform: uppercase;
letter-spacing: 0.5px;
margin: 16px 0 10px 0;
padding-bottom: 6px;
border-bottom: 2px solid #e8edf4;
text-align: left;
}
.country-flag {
position: relative;
display: inline-block;
cursor: pointer;
transition: transform 0.2s ease;
z-index: 10;
}
.country-flag:hover {
transform: scale(1.15);
z-index: 20;
}
.party-flag {
position: relative;
display: inline-flex;
align-items: center;
gap: 4px;
line-height: 1;
cursor: pointer;
transition: transform 0.2s ease;
z-index: 10;
font-size: 0;
}
.party-flag:hover {
transform: scale(1.05);
z-index: 20;
}
.country-flag .tooltip,
.party-flag .tooltip {
visibility: hidden;
background: #e42728 !important;
color: #fff !important;
text-align: center;
padding: 6px 10px;
border-radius: 6px;
position: absolute;
z-index: 100;
bottom: 100%;
margin-bottom: 8px;
left: 50%;
transform: translateX(-50%);
white-space: normal;
width: max-content;
max-width: 180px;
line-height: 1.4;
opacity: 0 !important;
transition: opacity 0.2s ease !important;
font-size: 10px !important;
font-weight: 500;
font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif;
pointer-events: none;
box-shadow: 0 4px 10px rgba(0, 0, 0, 0.15);
}
.country-flag:hover .tooltip,
.party-flag:hover .tooltip {
visibility: visible !important;
opacity: 1 !important;
}
.micro-badge-wrapper {
position: relative;
display: inline-flex;
flex-direction: column;
align-items: flex-start;
margin-bottom: 8px;
box-sizing: border-box !important;
}
.badge-link {
display: inline-flex;
align-items: center;
gap: 4px;
text-decoration: none !important;
transition: transform 0.2s ease, box-shadow 0.2s ease;
}
.badge-link:hover {
transform: translateY(-2px);
box-shadow: 0 4px 8px rgba(228, 39, 40, 0.15);
}
.tooltip-text {
visibility: hidden;
position: absolute;
bottom: 100%;
margin-bottom: 6px;
left: 50%;
transform: translateX(-50%);
background: #e42728 !important;
color: #fff !important;
border: none;
font-size: 10px !important;
font-weight: 500;
font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif;
padding: 6px 10px;
border-radius: 6px;
white-space: normal;
width: max-content;
max-width: 180px;
text-align: center;
line-height: 1.4;
opacity: 0 !important;
pointer-events: none;
transition: opacity 0.2s ease !important;
z-index: 100;
box-shadow: 0 4px 10px rgba(0, 0, 0, 0.15);
}
.micro-badge-wrapper:hover .tooltip-text,
.badge-link:focus + .tooltip-text {
visibility: visible !important;
opacity: 1 !important;
}
.programme-row {
border-left: 4px solid transparent;
transition: background-color 0.3s ease, border-color 0.3s ease, transform 0.3s ease;
box-sizing: border-box !important;
}
.programme-row:hover {
background-color: #f8fbff;
border-left-color: #e42728;
transform: translateX(6px);
}
.time-badge {
transition: transform 0.3s cubic-bezier(0.175, 0.885, 0.32, 1.275), box-shadow 0.3s ease;
}
.programme-row:hover .time-badge {
transform: scale(1.08);
box-shadow: 0 6px 12px rgba(228, 39, 40, 0.25);
}
.anchor-link {
display: inline-flex;
align-items: center;
font-size: 12px;
color: #e42728;
font-weight: 700;
text-decoration: none;
background: #fce9e9;
padding: 4px 12px;
border-radius: 20px;
white-space: nowrap;
transition: all 0.2s ease;
border: 1px solid transparent;
}
.anchor-link:hover {
background: #e42728;
color: #fff;
transform: translateY(-2px);
box-shadow: 0 4px 8px rgba(228, 39, 40, 0.15);
border-color: #b81e1e;
}
.host-card {
transition: transform 0.2s ease, box-shadow 0.2s ease;
}
.host-card:hover {
transform: translateY(-2px);
box-shadow: 0 12px 30px rgba(228, 39, 40, 0.12) !important;
}
@media (max-width: 768px) {
.tooltip,
.tooltip-text {
display: none !important;
}
}
https://www.expert-europe.eu/en/event/patients-over-patents-the-left-alternative-for-a-public-eu-pharma-industry/2026/06/09/467
MEP 
France 
Belgium 
Portugal 
